Vanguard Personalized Indexing Management, LLC Recursion Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 11,256 shares of RXRX stock, worth $46,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,256
Previous 12,153
7.38%
Holding current value
$46,599
Previous $61,000
11.48%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RXRX
# of Institutions
360Shares Held
301MCall Options Held
7.71MPut Options Held
4.85M-
Vanguard Group Inc Valley Forge, PA39.8MShares$165 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.5MShares$139 Million1.15% of portfolio
-
Baillie Gifford & CO24MShares$99.3 Million0.09% of portfolio
-
State Street Corp Boston, MA18.3MShares$75.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$71.7 Million0.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $747M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...